Developments and Current Treatment Standards in Cervical Cancer: Focus on Invasive Disease

Authors: Rein, Daniel T.1; Dall, Peter1; Kurbacher, Christian M.2; Breidenbach, Martina3

Source: American Journal of Cancer, Volume 4, Number 6, 2005 , pp. 373-381(9)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

The prognosis of patients with cervical cancer has improved dramatically in the last 20 years due to the success of systematic screening programs; however, the disease remains a major health problem worldwide. Patients with advanced, recurrent or metastatic disease still have a poor prognosis. Over the last century, radical surgery and radiotherapy have been used to improve survival rates in patients with primary cervical cancer. Both methods have been extensively modified over the years; however, neither improvements in surgical therapy (e.g. radical lymph node dissection) nor modified radiotherapy methods (e.g. neutron irradiation, hyperthermia, interstitial brachytherapy) have significantly decreased the mortality rates. Recently, cooperative clinical trials have demonstrated the superiority of multimodality strategies for patients with high-risk cervical cancer. In these studies, chemotherapy has been integrated into primary therapy; results have shown the most significant improvement of locally advanced disease in more than three decades. The introduction of modern surgical techniques, such as laparoscopic lymphonodectomy and radical pelvic exenteration, are new developments that will change the treatment of cervical cancer in the near future. This review summarizes different aspects of cervical cancer therapy, with emphasis on invasive disease, and provides a perspective on developments which may improve both local and systemic treatment of the disease.

Keywords: Antineoplastics; Cervical cancer; Radiotherapy; Surgery

Document Type: Review article

Affiliations: 1: 1 Department of Gynecology and Obstetrics, University of Düsseldorf Medical Center, Düsseldorf, Germany 2: 2 Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, University of Cologne Medical Center, Cologne, Germany 3: 3 Department of Gynecology and Obstetrics, University of Aachen Medical Center, Aachen, Germany

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$57.95 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A